Friday, January 17, 2014
High Potassium Intake Blunts the Effects of High Sodium on Blood Pressure
Cyst Growth Important for ADPKD Pathogenesis
Are Home Hemodialysis and High-Dose Hemodialysis Better for Patients? Many Nephrologists Say Yes
Study: Cigarettes increased nicotine content over last 15 years.
The Boston Globe (1/16, Kotz) reports a Massachusetts Department of Public Health and University of Massachusetts Medical School study published online in the journal Nicotine and Tobacco Research indicates that particular cigarette manufacturers have increased the nicotine in their product. Researchers found the average cigarette contained 1.65 milligrams of the substance in 1999, but increased 15% to 1.89 milligrams in 2011. Study leader Thomas Land believes the increase may have resulted from redesigning several brands with alterations on filters or product length.
The Springfield (MA) Republican (1/16, Flynn) also quotes Land as saying, “Cigarettes are getting more efficient at delivering nicotine to smokers. This could make it more difficult for a current smoker who is trying to quit, and easier for a young smoker to become addicted.”
Wednesday, January 15, 2014
FDA advisory panel backs orthostatic hypotension medication.
Bloomberg News (1/14, Edney) reports that “Chelsea Therapeutics International Ltd. won the backing of” an FDA advisory panel “for its drug to prevent sudden drops in blood pressure, a boost for the company’s effort to bring its first product to market.” The piece notes that “many panel members who voted in favor of approval said Chelsea showed the drug works short-term, and that initially is enough for such a rare, devastating disease with no other treatment options.”
Reuters (1/15, Clarke) reports that the drug, Nothera (droxidopa), is for patients with neurogenic orthostatic hypotension (NOH), a rare, chronic type of low blood pressure that is linked with certain neurological disorders such as Parkinson’s disease.
The AP (1/14) and MedPage Today (1/15) also report this story.